DAVENPORT & Co LLC Acquires 76,540 Shares of Cognex Corporation $CGNX

DAVENPORT & Co LLC lifted its holdings in shares of Cognex Corporation (NASDAQ:CGNXFree Report) by 19.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 477,658 shares of the scientific and technical instruments company’s stock after acquiring an additional 76,540 shares during the quarter. DAVENPORT & Co LLC owned approximately 0.29% of Cognex worth $17,186,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. AQR Capital Management LLC increased its position in Cognex by 18,810.9% during the 2nd quarter. AQR Capital Management LLC now owns 1,794,649 shares of the scientific and technical instruments company’s stock valued at $56,657,000 after purchasing an additional 1,785,159 shares during the period. Norges Bank bought a new position in Cognex in the 2nd quarter worth $38,889,000. Electron Capital Partners LLC lifted its position in shares of Cognex by 286.5% in the 2nd quarter. Electron Capital Partners LLC now owns 1,337,608 shares of the scientific and technical instruments company’s stock worth $42,429,000 after purchasing an additional 991,567 shares during the period. Nordea Investment Management AB lifted its position in shares of Cognex by 13.4% in the 3rd quarter. Nordea Investment Management AB now owns 8,025,371 shares of the scientific and technical instruments company’s stock worth $361,382,000 after purchasing an additional 949,599 shares during the period. Finally, Bank of New York Mellon Corp boosted its stake in shares of Cognex by 43.9% during the 3rd quarter. Bank of New York Mellon Corp now owns 3,024,355 shares of the scientific and technical instruments company’s stock valued at $137,003,000 after purchasing an additional 922,149 shares in the last quarter. Hedge funds and other institutional investors own 88.12% of the company’s stock.

Insider Activity

In related news, Director Robert Willett sold 177,052 shares of the firm’s stock in a transaction that occurred on Thursday, February 12th. The stock was sold at an average price of $58.39, for a total transaction of $10,338,066.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Angelos Papadimitriou sold 4,150 shares of Cognex stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $55.58, for a total value of $230,657.00. Following the transaction, the director owned 16,222 shares of the company’s stock, valued at $901,618.76. The trade was a 20.37% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 196,083 shares of company stock worth $11,419,321. Insiders own 1.70% of the company’s stock.

Cognex Price Performance

NASDAQ:CGNX opened at $51.61 on Thursday. The firm’s 50-day moving average price is $48.18 and its 200-day moving average price is $43.53. The company has a market capitalization of $8.62 billion, a PE ratio of 77.03 and a beta of 1.46. Cognex Corporation has a 1-year low of $22.67 and a 1-year high of $59.88.

Cognex (NASDAQ:CGNXGet Free Report) last issued its quarterly earnings results on Wednesday, February 11th. The scientific and technical instruments company reported $0.27 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. Cognex had a net margin of 11.51% and a return on equity of 9.02%. The company had revenue of $252.34 million during the quarter, compared to analysts’ expectations of $238.92 million. During the same period last year, the company posted $0.16 EPS. Cognex’s revenue was up 9.9% on a year-over-year basis. Equities analysts anticipate that Cognex Corporation will post 0.61 EPS for the current fiscal year.

Cognex Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 12th. Stockholders of record on Thursday, February 26th were issued a dividend of $0.085 per share. This represents a $0.34 annualized dividend and a dividend yield of 0.7%. The ex-dividend date was Thursday, February 26th. Cognex’s dividend payout ratio (DPR) is presently 50.75%.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on CGNX shares. JPMorgan Chase & Co. upgraded shares of Cognex from an “underweight” rating to a “neutral” rating and set a $55.00 price target on the stock in a research report on Monday, March 9th. Needham & Company LLC raised their price objective on shares of Cognex from $47.00 to $67.00 and gave the stock a “buy” rating in a report on Thursday, February 12th. Barclays lifted their price objective on Cognex from $61.00 to $64.00 and gave the company an “overweight” rating in a research report on Monday, March 16th. Cantor Fitzgerald reissued an “overweight” rating and issued a $63.00 target price on shares of Cognex in a research report on Friday, February 13th. Finally, DA Davidson set a $55.00 target price on Cognex and gave the company a “neutral” rating in a research note on Tuesday, February 17th. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, Cognex currently has an average rating of “Moderate Buy” and an average price target of $57.00.

Read Our Latest Research Report on CGNX

Cognex Profile

(Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

Further Reading

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNXFree Report).

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.